1. What Is an scFv Antibody Library?
A phage display library is a new technology that fuses exogenous proteins or peptides to phage coat proteins, displays them on the phage surface while maintaining a specific spatial conformation, and uses specific affinity to screen for specific proteins or peptides.
Single-chain Fv (scFv) fragments consist of the smallest functional antigen-binding domain of an antibody (~30 kDa), in which the variable heavy chain (VH) and variable light chain (VL) are linked together by a peptide linker. An antibody library refers to a collection of a large number of distinct clones generated by applying various strategies and methods—such as amino acid mutations and frameshift mutations—to the genes encoding the variable regions (VH and VL) of antibodies, particularly the CDR regions (complementary determining regions), from which high-affinity single-chain Fv antibodies targeting the target antigen are screened.

Figure 1: Schematic diagram of an SCFV antibody
2. Advantages of ScFv Antibody Libraries
ScFv fragments retain the binding specificity of their parent antibodies and offer several advantages over full-length mAbs.
(1) They possess pharmacokinetic properties—such as improved tissue penetration and rapid clearance from the bloodstream—that are beneficial for radiotherapy and diagnostic applications. For example, compared to full-length antibodies, these fragments can penetrate tumors more rapidly; when scFvs are conjugated with radionuclides in radiotherapy applications, their increased clearance from the bloodstream minimizes exposure to healthy tissues.
(2) Recombinant antibodies lack the Fc region, resulting in low immunogenicity; therefore, they serve as better therapeutic agents than full-length mAbs in many applications.
(3) scFvs can be cloned and expressed in both bacterial and mammalian cells, enabling easy and cost-effective large-scale production.
3. Applications of scFv Antibody Libraries
scFv antibodies play a significant role in the development of human life sciences. For example, they serve as tools for studying protein function and treating cancer; due to their small size, they can bind to quantum dots and nanoparticles, enabling them to enter the body and target specific sites, and act as carriers for drugs or nanoparticles.
4. KMD Bioscience Provides High-Quality scFv Antibody Phage Display Services
KMD Bioscience has been dedicated to research in the field of antibodies for many years. We have accumulated extensive experience in antibody library construction and are able to provide clients with single-chain Fv (scFv) antibody library construction services based on phage display technology, enabling the production of high-affinity, structurally stable scFv antibodies.
5. Overview of the Full Process for KMD Bioscience’s scFv Antibody Library Construction Services
KMD Bioscience provides clients with phage display library construction services, which include the following steps: antibody cDNA preparation, gene amplification, vector construction, electroporation, antibody screening, and scFv library packaging.

Figure 2: Workflow for constructing an antibody library using SCFV phages
5.1 Antibody cDNA Preparation
5.1.1 Total RNA Extraction
Remove peripheral blood lymphocytes from the refrigerator and aliquot them. Add chloroform, centrifuge, and collect the supernatant. Add isopropanol, centrifuge to collect the pellet, add 75% ethanol, centrifuge again to collect the pellet, dry the pellet, add DEPC-treated water, and incubate to ensure RNA dissolution. Combine the contents of all tubes into a single tube to obtain total RNA. Take 1 μL of total RNA for electrophoresis, and take 2 μL to measure the concentration using a nucleic acid concentration meter.
5.1.2 Reverse Transcription to Obtain cDNA
Prepare cDNA according to the instructions for the commercial kit. Divide the RNA obtained in the previous step into two portions and reverse-transcribe them into cDNA, using an Oligo dT primer and random 6-mers as reverse-transcription primers, respectively.
5.2 Gene Amplification
First, amplify the variable regions of the VH and VL (Vκ/Vλ) chains using cDNA as a template through two rounds of PCR. Each 50 µl PCR reaction contains 2 µl cDNA (40 ng/µl), 1 µl forward primer (10 µM), 1 µl reverse primer (10 µM), 0.5 µl Q5 DNA polymerase, 1 µl dNTP mix (10 µM), and 34.5 µl dd H₂O. The PCR products were then recovered. Finally, the VH and VL adapters were ligated via overlapping PCR.

Figure 3: Results of the Second Round of PCR Amplification
5.3 Vector Construction
The PCR-amplified scFv product was ligated into the phage plasmid pADL-10b via restriction enzyme digestion, thereby constructing a phage plasmid library containing the amplified fragment. The ligation product was purified using a DNA purification kit according to the manufacturer’s instructions, and 2 μL of the purified product was taken to measure its concentration using a nucleic acid concentration meter.
5.4 Electroporation
5.4.1 The ligation products were subjected to electroporation to construct an E. coli library containing the target antibody fragment.
Take E. coli SS320 competent cells, add the recovered ligation products, and transfer the mixture of competent cells and ligation products to a pre-chilled electroporation cup. Perform electroporation using the pre-set transformation program on the electroporator. Immediately after electroporation, add 950 μL of SOC medium to the electroporation cup. Perform at least 20 electroporation cycles. After resuspending the cells, spread them onto agar plates containing ampicillin resistance and allow them to grow overnight. Scrape the cells from the plates that have grown overnight using 2x YT medium and a spreader, add 20% glycerol, measure the OD600 nm value, and store at -80°C; this constitutes the bacterial library.
5.4.2 Phage Library Amplification
Mix the cells scraped from the plate in the previous step and transfer them to 100 mL of 2x YT medium pre-treated with tetracycline. Incubate at 37°C and 250 rpm until the OD₆₀₀ reaches 0.5–0.55.
Add helper phages at a ratio of 20:1 (helper phages to bacterial cells) and continue incubation at 37°C for 30 minutes. Add Kana to a final concentration of 50 µg/mL and PTG to a final concentration of 0.2 mM, then incubate overnight on a shaking incubator at 30°C.
5.4.3 Phage Library Preparation
Centrifuge the overnight bacterial culture at 4°C and 4000 rpm for 20 minutes. Transfer the supernatant to a new centrifuge tube, add 1/4 of the volume of pre-chilled 20% PEG/2.5 M NaCl, and incubate on ice for 30 minutes. Centrifuge at 4°C and 4000 rpm for 20 minutes to remove the supernatant, then add 1 mL of PBS buffer to resuspend the pellet. Add another 1/4 volume of pre-chilled 20% PEG/2.5 M NaCl and incubate on ice for 10 minutes. Centrifuge at 4°C and 12,000 xg for 10 minutes, remove the supernatant, and dissolve the pellet in 1 mL of PBS to obtain the phage library. Store long-term at −80°C; for short-term storage (1–2 weeks), store at 4°C.
5.5 Antibody Identification
Randomly select 20–50 clones to determine the PCR positivity rate, and sequence and analyze the antibody sequences.

Figure 4: Positive rate: >90%
5.6 scFv Library Packaging
Delivered at >1x10^13 phage particles/mL.
Since their introduction in 1988, scFvs have become highly relevant in preclinical and clinical applications as well as in research laboratories. Advances in antibody engineering have enabled the production of highly customized scFvs with improved pharmacokinetic properties, making them more clinically relevant. Coupling these recombinant antibodies to various particles has expanded their potential in diagnostic, therapeutic, and in vivo imaging applications. KMD Bioscience has been dedicated to phage library display technology for many years, utilizing multiple display systems including M13, T4, and T7. The scFv phage libraries we construct have high capacity, with 10^7–10^12 independent clones, and are prepared according to customer requirements, with experimental protocols tailored to each client’s needs.
0